Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JenaFlu
- Development stage
- Unknown
- Lead developer
- Jena Herbals
- Administration
- Oral
01
Overview
JenaFlu is an herbal medicine developed by Jena Herbals Limited, a company based in Uganda. It is officially approved by the Uganda National Drug Authority (NDA) as a finished commercial product for the treatment of flu and related symptoms. Unlike conventional synthetic pharmaceuticals, JenaFlu is a botanical formulation derived from traditional medicinal knowledge. It is part of a portfolio of herbal products produced by Jena Herbals, which gained significant attention for products like Covidex during the COVID-19 pandemic. The product is marketed as a natural remedy to alleviate symptoms associated with the common cold and influenza.
- Brand names
- JenaFlu
- Other names
- JenaFlu
Beyond the preview
Go deeper on JenaFlu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JenaFlu.